Pain Drugs
512 FDA-approved drugs
TheraRadar tracks 512 FDA-approved pain drugs from 226 companies across 11 drug classes, led by Pfizer, with 753 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Pain.
Pain Approvals by Year
8
'15
4
'16
5
'17
10
'18
3
'19
5
'20
5
'21
'22
3
'23
3
'24
5
'25
1
'26
Recent Pain Drug Approvals
TAPENTADOL HYDROCHLORIDE
TAPENTADOL HYDROCHLORIDE
the management of acute pain severe enough to require an opioid analgesic and for which alternative ...
2026-01-26
Hikma
BONDLIDO
LIDOCAINE
BONDLIDO (lidocaine topical system 10%) is indicated in adults for relief of pain associated with po...
2025-09-24
MEDRX USA
XIFYRM
MELOXICAM
use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID ...
2025-06-05
AZURITY
PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
PHENYLEPHRINE HYDROCHLORIDE
Uses temporarily relieves these common cold and flu symptoms: cough nasal congestion minor aches and...
2025-05-30
Dr. Reddy's
QAMZOVA
MELOXICAM
use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID ...
2025-04-22
NANJING DELOVA
JOURNAVX
SUZETRIGINE
moderate to severe acute pain, including postoperative pain, in adults...
2025-01-30
Vertex Pharmaceuticals
BUPIVACAINE LIPOSOME
BUPIVACAINE
2024-07-01
HENGRUI PHARMA
REZENOPY
NALOXONE HYDROCHLORIDE
the management of pain severe enough to require an opioid analgesic and for which alternative treatm...
2024-04-19
SCIENTURE
Opioid receptor
BYQLOVI
CLOBETASOL PROPIONATE
post-operative inflammation and pain following ocular surgery...
2024-03-04
HARROW EYE
COMBOGESIC IV
ACETAMINOPHEN
short-term use of five days or less...
2023-10-17
Hikma
COMBOGESIC
ACETAMINOPHEN
COMBOGESIC is indicated in adults for the short-term management of mild to moderate acute pain...
2023-03-01
AFT PHARMS US
ACETAMINOPHEN AND IBUPROFEN
ACETAMINOPHEN
2023-02-28
STRIDES PHARMA
SEGLENTIS
CELECOXIB
2021-10-15
KOWA PHARMS
DIFLUPREDNATE
DIFLUPREDNATE
inflammation and pain associated with ocular surgery...
2021-08-09
AMNEAL
IBUPROFEN AND FAMOTIDINE
FAMOTIDINE
the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk...
2021-08-03
Teva
HYDROCODONE BITARTRATE AND ASPIRIN
ASPIRIN
Uses for the temporary relief of minor aches and pains or as recommended by your doctor...
2021-05-28
LGM PHARMA
POSIMIR
BUPIVACAINE
2021-02-01
INNOCOLL
QDOLO
TRAMADOL HYDROCHLORIDE
2020-09-01
ROSEMOUNT
OLINVYK
OLICERIDINE
2020-08-07
TREVENA
ADVIL DUAL ACTION WITH ACETAMINOPHEN
ACETAMINOPHEN
2020-02-28
HALEON US HOLDINGS
Showing the 20 most recent of 512 pain drugs. View all 512 →
Top Pain Companies
Pain Active Trials by Indication
753 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Pain Drug Classes
Nonsteroidal Anti-inflammatory Drug 18
Amide Local Anesthetic 4
Barbiturate 4
Partial Opioid Agonist 2
Non-Standardized Chemical Allergen 2
Non-Standardized Food Allergenic Extract 2
Sodium Channel Blocker 1
Histamine-2 Receptor Antagonist 1
Opioid Agonist 1
Nitrate Vasodilator 1
Pain at a Glance
- Total Drugs
- 512
- Companies
- 226
- Drug Classes
- 11
- Active Trials
- 753
- Latest Approval
- 2026-01-26